These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26507306)

  • 1. Counterpoint: epidemiology to guide decision-making: moving away from practice-free research.
    Hernán MA
    Am J Epidemiol; 2015 Nov; 182(10):834-9. PubMed ID: 26507306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vandenbroucke and Pearce respond to "incident and prevalent exposures and causal inference".
    Vandenbroucke J; Pearce N
    Am J Epidemiol; 2015 Nov; 182(10):846-7. PubMed ID: 26507304
    [No Abstract]   [Full Text] [Related]  

  • 4. A Future for Observational Epidemiology: Clarity, Credibility, Transparency.
    Harper S
    Am J Epidemiol; 2019 May; 188(5):840-845. PubMed ID: 30877294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship-Observational Studies.
    Snyder GM; Young H; Varman M; Milstone AM; Harris AD; Munoz-Price S
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1141-6. PubMed ID: 27322190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The limitations of observation studies for decision making regarding drugs efficacy and safety.
    Gueyffier F; Cucherat M
    Therapie; 2019 Apr; 74(2):181-185. PubMed ID: 30514576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confounding in health research.
    Greenland S; Morgenstern H
    Annu Rev Public Health; 2001; 22():189-212. PubMed ID: 11274518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterpoint: the treatment decision design.
    Brookhart MA
    Am J Epidemiol; 2015 Nov; 182(10):840-5. PubMed ID: 26507307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.
    Little RJ; Rubin DB
    Annu Rev Public Health; 2000; 21():121-45. PubMed ID: 10884949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the causal structure of information bias and confounding bias in randomized trials.
    Shahar E; Shahar DJ
    J Eval Clin Pract; 2009 Dec; 15(6):1214-6. PubMed ID: 20367730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What are the propensity scores?].
    Ojeda D; Gómez R; Burgos Á
    Rev Med Chil; 2016 Mar; 144(3):364-70. PubMed ID: 27299823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.
    Targownik LE; Suissa S
    Am J Gastroenterol; 2015 Dec; 110(12):1647-50. PubMed ID: 26323186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From observational studies to randomized trials: asking the right question at the right time.
    Neaton JD; Mugglin AS
    J Clin Periodontol; 2006 Aug; 33(8):517-9. PubMed ID: 16899092
    [No Abstract]   [Full Text] [Related]  

  • 14. Point: incident exposures, prevalent exposures, and causal inference: does limiting studies to persons who are followed from first exposure onward damage epidemiology?
    Vandenbroucke J; Pearce N
    Am J Epidemiol; 2015 Nov; 182(10):826-33. PubMed ID: 26507305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
    Chiba Y; Sato T; Greenland S
    Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observational studies: the hazard and other gods].
    Arenas-Fernández J; Fernández-Martín JL; Cannata-Andía JB; Martínez-Camblor P
    Med Clin (Barc); 2014 Jan; 142(2):80-4. PubMed ID: 23831405
    [No Abstract]   [Full Text] [Related]  

  • 18. Observational research--opportunities and limitations.
    Boyko EJ
    J Diabetes Complications; 2013; 27(6):642-8. PubMed ID: 24055326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping trials for efficacy: an almost unbiased view.
    Goodman SN
    Clin Trials; 2009 Apr; 6(2):133-5. PubMed ID: 19342465
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction and causal inference.
    Gagliardi L
    Acta Paediatr; 2009 Dec; 98(12):1890-2. PubMed ID: 20050836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.